These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3575744)

  • 1. To whom should we give the safer contrast media?
    Black WC
    Radiology; 1987 Jun; 163(3):831-2. PubMed ID: 3575744
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonionic agents: okay, they're safer--but how much safer and at what cost to society?
    Levin D
    Adm Radiol; 1990 Nov; 9(11):97-8. PubMed ID: 10113413
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonionic agents: okay, they're safer--now what?
    Wolf G
    Adm Radiol; 1990 Nov; 9(11):92, 96. PubMed ID: 10113412
    [No Abstract]   [Full Text] [Related]  

  • 4. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media.
    Thomsen HS
    Eur J Radiol; 2006 Dec; 60(3):307-13. PubMed ID: 16965884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular contrast media.
    Hosp Pharm; 1991 Mar; 26(3):275-6, 278. PubMed ID: 10113525
    [No Abstract]   [Full Text] [Related]  

  • 6. [Off-label-use of contrast media].
    Heinemann AK; Löllgen N
    Rofo; 2007 Aug; 179(8):867-8. PubMed ID: 17647165
    [No Abstract]   [Full Text] [Related]  

  • 7. Safer contrast media for X-ray examinations.
    Morgan BJ
    N Z Health Hospital; 1989; 41(2):13. PubMed ID: 10295400
    [No Abstract]   [Full Text] [Related]  

  • 8. Indications for the use of low-osmolar contrast agents.
    Bloom DM
    Physician Exec; 1989; 15(4):24-5. PubMed ID: 10313370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contraindications for contrast media--clarification and validity].
    Wigge P; Müller SC
    Rofo; 2007 Nov; 179(11):1205-7. PubMed ID: 17955418
    [No Abstract]   [Full Text] [Related]  

  • 10. ESUR guidelines on contrast media.
    Thomsen HS; Morcos SK;
    Abdom Imaging; 2006; 31(2):131-40. PubMed ID: 16447092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some aspects of adverse reactions during radiopaque studies].
    Sviridov NK
    Vestn Rentgenol Radiol; 1998; (1):58-60. PubMed ID: 9584657
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduced use of lower-osmolality contrast media resulting from an order form and guidelines.
    Swanson DP; Damiani-Hieronim DR; Baron RL
    Am J Hosp Pharm; 1994 Dec; 51(23):2952-5. PubMed ID: 7879806
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arrogant neurosugeons and knowledgeable radiologists].
    Malmros R
    Ugeskr Laeger; 1988 May; 150(22):1369-71. PubMed ID: 3376322
    [No Abstract]   [Full Text] [Related]  

  • 14. European Society of Urogenital Radiology guidelines on contrast media application.
    Thomsen HS;
    Curr Opin Urol; 2007 Jan; 17(1):70-6. PubMed ID: 17143114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management issues in the use of iodinated radiopaque contrast media.
    Ratko T
    QRC Advis; 1994 Jun; 10(8):1-3. PubMed ID: 10134831
    [No Abstract]   [Full Text] [Related]  

  • 16. 100% nonionics: everything added up.
    von Kaenel LH; Modic M
    Adm Radiol; 1990 Nov; 9(11):100-6. PubMed ID: 10113410
    [No Abstract]   [Full Text] [Related]  

  • 17. An institutional approach to developing guidelines for the use of low-osmolality contrast agents.
    Swanson DP
    Appl Radiol; 1988 May; 17(5):27-8. PubMed ID: 10287384
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes & choices. AR nationwide survey.
    Tsuchiyama S
    Adm Radiol; 1988 Nov; 7(11):70-4, 76-8. PubMed ID: 10291083
    [No Abstract]   [Full Text] [Related]  

  • 19. Hospitals begin cutting non-ionic contrast agent use.
    Werner C
    Hosp Mater Manage; 1993 Oct; 18(10):1, 11-2. PubMed ID: 10129785
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacist-managed monitoring of adverse reactions to contrast media.
    Damiani DR; Swanson DP
    Am J Hosp Pharm; 1994 Feb; 51(3):358-63. PubMed ID: 8160688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.